Psychiatry

814 questions

Question 481Question →

A forensic psychiatrist is reviewing the medical file of a female inmate being evaluated for transfer to a long-term psychiatric facility. Comprehensive longitudinal medical records indicate that her psychiatric illness began exactly 10 years ago with the insidious onset of auditory hallucinations, persecutory delusions, and severe avolition. Over this entire 10-year period, these psychotic symptoms have been continuously present on a daily basis without any periods of remission. The records also reveal that 8 years ago, she suffered a distinct 6-month period of profound anhedonia, hypersomnia, and feelings of worthlessness. Four years ago, she had a 3-month episode characterized by pressured speech, grandiosity, and a decreased need for sleep. There are no other documented mood episodes throughout her lifespan. Toxicology screens and medical evaluations have been consistently unremarkable throughout her incarceration and previous hospitalizations. Based on the patient's longitudinal history, which of the following is the most appropriate DSM-5 diagnosis?

Show answer & explanation

Answer: Schizophrenia

Answer

Schizophrenia
The correct diagnosis is schizophrenia. This patient has a 10-year (120-month) history of continuous psychotic symptoms, satisfying the core criteria for schizophrenia. While she has a history of both a major depressive episode and a manic episode, the cumulative duration of these mood episodes is only 9 months. According to DSM-5 criteria, a diagnosis of schizoaffective disorder requires that symptoms meeting the criteria for a major mood episode be present for the *majority* (greater than 50%) of the total duration of the active and residual portions of the illness. Because 9 months is a small minority (7.5%) of her 10-year illness, the criteria for schizoaffective disorder are not met, and the diagnosis remains schizophrenia.

Step-by-Step Solution

1
Analyze the duration and continuity of psychotic symptoms.
The patient has experienced hallucinations, delusions, and avolition continuously for 10 years (120 months).
This establishes that Criterion A for a schizophrenia spectrum disorder is met and confirms an active psychotic illness.
2
Calculate the total duration of all major mood episodes.
The patient had one depressive episode (6 months) and one manic episode (3 months), totaling 9 months of active mood symptoms.
Tracking mood episode duration is required to differentiate schizophrenia from schizoaffective disorder.
3
Compare the duration of mood episodes to the total duration of the psychotic illness.
The 9 months of mood symptoms constitute 7.5% of the 120-month total illness duration.
DSM-5 Criterion C for schizoaffective disorder dictates that mood episodes must be present for the majority (>50%) of the total active and residual portions of the illness.
4
Synthesize findings to confirm the final diagnosis.
Because mood symptoms do not account for the majority of the illness, the diagnosis defaults to schizophrenia rather than schizoaffective disorder.
Applying the strict longitudinal timeline rules eliminates other differential diagnoses.

Key Concept

To diagnose schizoaffective disorder, mood episodes must be present for the majority (>50%) of the total duration of the active and residual portions of the illness; if they are not, the diagnosis is schizophrenia.
Question 482Question →

Match each patient's comprehensive clinical vignette to the most accurate psychiatric diagnosis.

Click a left item, then click its matching right item

Items

A 19-year-old college freshman reports feeling tearful and having difficulty sleeping for the past 2 months since moving away from home. She feels overwhelmed by classes but denies anhedonia, guilt, or suicidal ideation. She is able to attend classes and feels her mood improve significantly when visiting her family.
A 28-year-old man presents with a 4-week history of severe anhedonia, hypersomnia, and feelings of worthlessness. Upon detailed screening, he reports a distinct 6-day period last year where he felt uncharacteristically energetic, slept only 3 hours a night without feeling tired, and impulsively bought a sports car he could not afford.
A 45-year-old woman develops severe depressed mood, emotional lability, and profound insomnia. These symptoms began two weeks after she was prescribed high-dose oral prednisone to manage a severe systemic lupus erythematosus flare. Prior to this, she had no history of psychiatric illness.
A 35-year-old woman presents with a 6-week history of pervasive sadness, inability to enjoy her usual hobbies, early morning awakenings, a 5-kg (11-lb) weight loss, and difficulty concentrating at work. She reports feeling guilty over minor past mistakes and states her performance at work has severely declined.

Matches

Show answer & explanation

Answer

The college student with homesickness has an adjustment disorder. The man with current depression and past hypomania has bipolar disorder. The woman on prednisone has a medication-induced depressive disorder. The woman with 6 weeks of pervasive anhedonia and somatic symptoms has major depressive disorder.
Correct diagnosis in depressive disorders relies on precise pattern recognition: distinguishing the sub-threshold, stressor-related presentation of adjustment disorder; identifying past hypomanic episodes that define bipolar disorder; recognizing temporal associations with offending agents like glucocorticoids; and confirming the full symptom cluster required for major depressive disorder.

Step-by-Step Solution

1
Analyze the timeline, symptom severity, and functional impairment of each clinical vignette.
Identified that the 19-year-old does not meet full MDD criteria and has a clear stressor. The 35-year-old fully meets MDD criteria with marked functional impairment.
Differentiating major depressive disorder from adjustment disorder requires evaluating symptom count (at least 5 for MDD) and severity of functional impairment.
2
Screen for history of elevated mood or external triggers (medications/substances).
The 28-year-old has a history of a 6-day hypomanic episode. The 45-year-old's symptoms clearly align with the initiation of high-dose corticosteroids.
Failing to identify past hypomania/mania leads to inappropriate unipolar MDD treatment, and failing to recognize medication triggers leads to unnecessary primary psychiatric diagnoses.

Key Concept

Discrimination between unipolar major depressive disorder, bipolar depression, adjustment disorder, and substance/medication-induced depressive disorder based on clinical history and timeline.
Question 483Question →

Match each clinical presentation with the most appropriate psychiatric diagnosis.

Click a left item, then click its matching right item

Items

Sudden onset of unilateral blindness with completely normal ophthalmologic and neurologic exams after witnessing a traumatic accident.
Excessive preoccupation with having pancreatic cancer for 8 months despite negative workups, with no active physical symptoms.
Persistent, distressing abdominal pain and fatigue for over a year with excessive, disproportionate anxiety and time devoted to these symptoms despite negative medical evaluations.
Surreptitious self-injection of insulin resulting in recurrent hypoglycemia (high insulin, low C-peptide), done to assume the sick role without obvious external reward.

Matches

Show answer & explanation

Answer

The presentations match as follows: unilateral blindness with normal exams corresponds to Conversion disorder; preoccupation with pancreatic cancer without symptoms corresponds to Illness anxiety disorder; chronic abdominal pain and fatigue with excessive worry corresponds to Somatic symptom disorder; and surreptitious insulin injection to assume the sick role corresponds to Factitious disorder imposed on self.
Each clinical presentation uniquely aligns with the core diagnostic criteria of a specific disorder within the somatic symptom and related disorders spectrum. Correct identification relies on evaluating the presence and nature of somatic symptoms, whether symptoms are intentionally produced, and the underlying motivation (primary vs. secondary gain).

Step-by-Step Solution

1
Analyze the first presentation regarding sudden blindness.
Identified as a neurological symptom inconsistent with known medical disease, pointing to conversion disorder.
Conversion disorder involves altered voluntary motor or sensory deficits without underlying neurological pathology, often following acute stress.
2
Evaluate the second presentation involving cancer preoccupation.
Recognized as illness anxiety disorder.
The patient has no significant somatic symptoms but exhibits high anxiety and preoccupation about acquiring a severe illness.
3
Assess the third presentation with abdominal pain and fatigue.
Matched with somatic symptom disorder.
The patient has actual distressing somatic symptoms paired with excessive, disproportionate thoughts, feelings, and behaviors regarding them.
4
Examine the fourth presentation involving surreptitious insulin use.
Classified as factitious disorder.
The hypoglycemia is intentionally produced to assume the sick role (primary gain), rather than for external incentives like avoiding work or obtaining compensation (secondary gain).

Key Concept

Differentiation of somatic symptom and related disorders based on symptom presence, intentionality, and underlying motivation.
Question 484Question →

A 54-year-old man with a severe alcohol use disorder is brought to the emergency department by emergency medical services due to confusion and unsteadiness. He was found wandering in the street. His last alcoholic drink was approximately 24 hours ago. On presentation, he is diaphoretic, tachycardic (heart rate 118/min), and visibly tremulous. Neurologic examination reveals bilateral horizontal nystagmus, a wide-based ataxic gait, and profound global confusion. Point-of-care blood glucose testing shows 58 mg/dL (3.2 mmol/L). The patient is admitted to the hospital.

Arrange the following management steps in the most appropriate chronological sequence for this patient, from immediate acute stabilization to pre-discharge planning.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first administer intravenous thiamine, followed by intravenous dextrose, then initiate symptom-triggered intravenous lorazepam, perform a comprehensive psychosocial evaluation, and finally initiate oral naltrexone as maintenance pharmacotherapy.
The management of severe alcohol use disorder requires a structured, chronological approach that prioritizes immediate, life-threatening conditions before addressing long-term recovery. This patient presents with the classic triad of Wernicke encephalopathy (confusion, ataxia, nystagmus) and concurrent hypoglycemia. Because thiamine is an essential cofactor for glucose metabolism, administering glucose without thiamine can precipitate severe, irreversible neurologic damage. Therefore, intravenous thiamine is the absolute first step. Immediately following thiamine, intravenous dextrose is given to correct the hypoglycemia. Once these acute metabolic derangements are addressed, the focus shifts to treating his acute alcohol withdrawal (manifested by tremor, tachycardia, and diaphoresis) using symptom-triggered benzodiazepines such as lorazepam to prevent seizures and delirium tremens. After the patient is medically cleared, sober, and free of acute withdrawal symptoms, a comprehensive psychosocial evaluation is performed to gauge his readiness for behavioral change. Finally, as part of discharge planning, maintenance pharmacotherapy such as naltrexone is initiated to reduce cravings and prevent long-term relapse.

Step-by-Step Solution

1
Identify the immediate metabolic threats: Wernicke encephalopathy and hypoglycemia.
Recognize that thiamine must precede glucose administration.
Glucose metabolism rapidly utilizes thiamine as a cofactor. Administering glucose without thiamine to a malnourished patient can severely deplete remaining stores, worsening Wernicke encephalopathy.
2
Address the life-threatening hypoglycemia.
Administer intravenous dextrose.
A blood glucose level of 58 mg/dL contributes to global confusion and must be corrected immediately after thiamine is provided.
3
Manage the acute alcohol withdrawal syndrome.
Initiate symptom-triggered intravenous lorazepam.
The patient is diaphoretic, tachycardic, and tremulous approximately 24 hours after his last drink, indicating acute withdrawal. Benzodiazepines are required to prevent progression to withdrawal seizures or delirium tremens.
4
Transition to post-acute care and recovery planning.
Perform a comprehensive psychosocial evaluation.
Medical stabilization must be fully achieved before a meaningful assessment of the patient's support system, psychiatric comorbidities, and readiness to change can be conducted.
5
Initiate relapse prevention therapy.
Prescribe oral naltrexone.
Once the patient is detoxified, oriented, and assessed, long-term pharmacotherapy is initiated prior to discharge to reduce cravings and decrease the risk of relapse.

Key Concept

Sequential management of severe alcohol use disorder requires immediate metabolic stabilization (thiamine before dextrose), followed by acute withdrawal management (benzodiazepines), and finally post-acute rehabilitation (psychosocial evaluation and maintenance pharmacotherapy).
Question 485Question →

A 21-year-old female university student presents to the student health center accompanied by a residence hall advisor. The patient is visibly distraught, weeping uncontrollably, and stating that her life is 'completely empty' after a three-week romantic relationship ended abruptly the previous night. Physical examination reveals several superficial, linear scratches on her left volar forearm. She admits to making these marks with a safety pin, stating, 'I just needed to feel something.' The advisor mentions that the patient has a history of intense, unstable friendships, often idolizing peers before suddenly turning against them. The patient's medical history includes a diagnosis of 'atypical depression,' for which she currently takes phenelzine. During the interview, she mentions that last night she briefly suspected the campus security was tracking her phone, but she now realizes this was an irrational thought. She denies any current suicidal ideation or plan. Which of the following are appropriate next steps in the ongoing management of this patient? (Select all that apply.)

Select all that apply

Show answer & explanation

Answer: Provide a referral for dialectical behavior therapy; Establish clear, firm boundaries regarding the parameters of future clinical interactions

Answer

The most appropriate management steps for this patient include referring her for dialectical behavior therapy (DBT) and establishing clear, consistent clinical boundaries.
This patient's presentation—characterized by an intense fear of abandonment, unstable relationships, emotional lability, chronic feelings of emptiness, superficial self-injury, and transient stress-related paranoia—is highly consistent with borderline personality disorder (BPD). The primary, evidence-based treatment for BPD is dialectical behavior therapy (DBT), which focuses on emotional regulation, distress tolerance, and mindfulness. Additionally, patients with BPD often test limits and engage in splitting (idealizing and then devaluing providers). Therefore, establishing clear, consistent, and firm boundaries regarding communication and clinical availability is an essential component of management to ensure a stable therapeutic framework.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and history.
The patient displays emotional lability, chronic feelings of emptiness, superficial non-suicidal self-injury, intense unstable relationships, and transient stress-related paranoia.
Identifying the core pattern of symptoms is necessary to establish the primary psychiatric diagnosis of borderline personality disorder (BPD).
2
Determine the appropriate psychotherapeutic and interpersonal interventions for BPD.
Dialectical behavior therapy (DBT) is the evidence-based treatment of choice, and setting firm clinical boundaries prevents splitting and excessive dependency.
Psychotherapy is the mainstay of treatment for BPD, and clear boundaries protect both the patient and the therapeutic relationship.
3
Evaluate the proposed pharmacological and ethical interventions in the distractors.
Adding fluoxetine to phenelzine causes serotonin syndrome. Transient paranoia does not meet the timeline for schizophreniform disorder. Superficial self-harm does not justify breaching an adult's confidentiality.
To rule out contraindicated or inappropriate clinical actions based on patient safety and diagnostic criteria.

Key Concept

Management of borderline personality disorder (BPD)
Question 486Question →

A 1919-year-old man is brought to the emergency department by his friends due to severe agitation, confusion, and muscle twitching. The friends report they were at an electronic music festival where the patient consumed an unknown pill approximately 44 hours ago. His medical history is significant for major depressive disorder, for which he has been taking sertraline for the past 66 months.

Temperature is 39.6∘C39.6^\circ\text{C} (103.3∘F103.3^\circ\text{F}), blood pressure is 168/102 mm Hg168/102 \text{ mm Hg}, pulse is 132/min132/\text{min}, and respirations are 24/min24/\text{min}.

On examination, the patient is disoriented, markedly diaphoretic, and has mydriasis. Neurologic examination reveals shivering, hyperreflexia in the lower extremities, and sustained bilateral ankle clonus.

Laboratory studies reveal:

Laboratory ParameterResultReference Range
Sodium122 mEq/L122 \text{ mEq/L}136−145 mEq/L136-145 \text{ mEq/L}
Potassium4.0 mEq/L4.0 \text{ mEq/L}3.5−5.0 mEq/L3.5-5.0 \text{ mEq/L}
Bicarbonate24 mEq/L24 \text{ mEq/L}22−28 mEq/L22-28 \text{ mEq/L}
Blood urea nitrogen10 mg/dL10 \text{ mg/dL}7−18 mg/dL7-18 \text{ mg/dL}
Creatinine0.8 mg/dL0.8 \text{ mg/dL}0.6−1.2 mg/dL0.6-1.2 \text{ mg/dL}
Thyroid-stimulating hormone (TSH)2.1 μU/mL2.1 \ \mu\text{U/mL}0.5−5.0 μU/mL0.5-5.0 \ \mu\text{U/mL}

Urine toxicology screen is positive for amphetamines.

Which of the following is the most likely underlying mechanism for this patient's acute presentation?

Show answer & explanation

Answer: Synergistic elevation of intrasynaptic serotonin levels

Answer

Synergistic elevation of intrasynaptic serotonin levels
The correct answer identifies the pathogenesis of Serotonin Syndrome. This patient's triad of altered mental status, autonomic instability (hyperthermia, tachycardia, diaphoresis), and neuromuscular excitability (hyperreflexia, clonus) is classic for Serotonin Syndrome. He ingested an unknown pill at a music festival, which, given the clinical picture and positive amphetamine screen, is highly likely to be MDMA (ecstasy). MDMA is a synthetic amphetamine derivative that promotes the massive presynaptic release of serotonin, dopamine, and norepinephrine. His home medication, sertraline, is a selective serotonin reuptake inhibitor (SSRI). The combination of a serotonin-releasing agent (MDMA) and a reuptake inhibitor (sertraline) causes a massive synergistic accumulation of serotonin in the synaptic cleft, precipitating this crisis. Furthermore, MDMA frequently causes profound hyponatremia (as seen with this patient's sodium of 122 mEq/L122 \text{ mEq/L}) via drug-induced inappropriate antidiuretic hormone secretion (SIADH) and increased free water intake, which confirms the diagnosis.

Step-by-Step Solution

1
Evaluate the clinical presentation and vital signs.
The patient exhibits hyperthermia, tachycardia, diaphoresis, and altered mental status.
These signs indicate an acute hypermetabolic toxidrome, narrowing the differential to serotonergic, sympathomimetic, or anticholinergic toxicity.
2
Analyze the specific neurologic findings.
The presence of shivering, hyperreflexia, and sustained bilateral ankle clonus is noted.
Clonus and hyperreflexia are the hallmark distinguishing features of Serotonin Syndrome, separating it from neuroleptic malignant syndrome (which presents with 'lead-pipe' rigidity) and pure sympathomimetic toxicity.
3
Correlate the toxidrome with the patient's history and lab findings.
The patient took an unknown pill (MDMA/ecstasy) while on home sertraline, and labs show severe hyponatremia without an acid-base disturbance.
MDMA promotes massive serotonin release and uniquely causes SIADH-like hyponatremia. Combining MDMA with an SSRI (sertraline) prevents serotonin clearance, leading to a life-threatening synergistic serotonergic crisis.

Key Concept

MDMA (ecstasy) intoxication combined with selective serotonin reuptake inhibitors (SSRIs) can precipitate severe serotonin syndrome. Additionally, MDMA is unique among common drugs of abuse for causing profound hyponatremia.
Question 487Question →

A 1919-year-old male collegiate wrestler is brought to the student health center due to profound fatigue, dizziness, and muscle cramps over the past two weeks. He has been intensely focused on "making weight" for the upcoming wrestling season. His BMI is 21.5 kg/m221.5 \text{ kg/m}^2. Vital signs show temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), pulse 112112/min, respirations 1212/min, and blood pressure 96/60 mm Hg96/60 \text{ mm Hg}. Physical examination reveals dry mucous membranes, bilateral parotid gland swelling, and calluses on the dorsum of his right hand. The lungs are clear to auscultation, and the heart has a regular rhythm with no murmurs.

Laboratory studies show:
Sodium: 138 mEq/L138 \text{ mEq/L}
Potassium: 2.6 mEq/L2.6 \text{ mEq/L}
Chloride: 86 mEq/L86 \text{ mEq/L}
Bicarbonate: 36 mEq/L36 \text{ mEq/L}
Thyroid-stimulating hormone (TSH): 1.2 μU/mL1.2 \text{ }\mu\text{U/mL} (normal 0.40.4-4.04.0)
Free T4: 0.7 ng/dL0.7 \text{ ng/dL} (normal 0.90.9-2.42.4)

An arterial blood gas on room air shows pH 7.527.52 and PaCO2 48 mm Hg48 \text{ mm Hg}. An ECG reveals sinus tachycardia with flattened T waves and prominent U waves.

Which of the following is the most accurate statement regarding this patient's condition?

Show answer & explanation

Answer: The arterial carbon dioxide level reflects appropriate physiological compensation.

Answer

The arterial carbon dioxide level reflects appropriate physiological compensation.
The correct answer accurately interprets the patient's acid-base status. The patient's self-induced vomiting (suggested by parotid swelling and Russell sign) has caused a hypokalemic, hypochloremic metabolic alkalosis. In metabolic alkalosis, the expected respiratory compensation (hypoventilation) is calculated as: Expected PaCO2 = 40+[0.7×(HCO3−−24)]±240 + [0.7 \times (\text{HCO}_3^- - 24)] \pm 2. For this patient, Expected PaCO2 = 40+0.7(12)=48.4±2 mm Hg40 + 0.7(12) = 48.4 \pm 2 \text{ mm Hg}. The patient's measured PaCO2 of 48 mm Hg48 \text{ mm Hg} falls perfectly within this range, indicating appropriate respiratory compensation without a superimposed respiratory acid-base disorder.

Step-by-Step Solution

1
Identify the primary psychiatric and medical diagnosis.
The patient has Bulimia Nervosa, evidenced by normal BMI, purging signs (Russell sign, parotid swelling), and volume depletion.
Recognizing the eating disorder contextualizes the electrolyte abnormalities, specifically vomiting-induced hypokalemia and metabolic alkalosis.
2
Analyze the primary acid-base disturbance.
The arterial blood gas shows alkalemia (pH 7.527.52) with a high bicarbonate (36 mEq/L36 \text{ mEq/L}), confirming a primary metabolic alkalosis.
Vomiting causes loss of gastric acid (HCl) and volume depletion, driving aldosterone-mediated bicarbonate retention and potassium wasting.
3
Calculate the expected respiratory compensation for the metabolic alkalosis.
Expected PaCO2 = 40+[0.7×(36−24)]=40+8.4=48.4 mm Hg±240 + [0.7 \times (36 - 24)] = 40 + 8.4 = 48.4 \text{ mm Hg} \pm 2.
To determine if there is a mixed acid-base disorder, the measured PaCO2 (48 mm Hg48 \text{ mm Hg}) must be compared to the expected PaCO2 (46.4−50.4 mm Hg46.4 - 50.4 \text{ mm Hg}). Since it falls within the range, compensation is appropriate.

Key Concept

Metabolic complications of purging behavior and acid-base compensation calculations

Alternative Method

When evaluating complex patients, group the findings by organ system. The calluses and parotid swelling quickly isolate the psychiatric diagnosis (Bulimia Nervosa). The labs isolate the nephrology diagnosis (metabolic alkalosis). Evaluating the answers sequentially against these isolated domains saves time.
Estimated Time:1m 30s
Question 488Question →

An outpatient psychiatric consultation is requested for a 42-year-old female patient experiencing debilitating, multi-domain worry. Over the last 7 months, she has been unable to control her persistent apprehension regarding her career stability, household finances, and the well-being of her children. These pervasive concerns are accompanied by chronic cervical muscle tension, poor concentration, and prominent fatigue. She denies any prior manic or hypomanic episodes.

Four weeks ago, the patient began taking phenelzine for refractory atypical depression. While her mood has significantly brightened, her anxiety symptoms have remained unchanged. At age 20, she experienced a discrete 14-day period characterized by intense auditory hallucinations and paranoid delusions, which resolved entirely without long-term sequelae.

Midway through the consultation, the clinic's front desk forwards a phone call from the patient's supervisor. The supervisor wishes to verify that the patient is receiving medical care so that her paid leave can be formally approved. The patient has not completed any release of information forms.

Recent laboratory investigations reveal:
Thyroid-stimulating hormone (TSH): 2.4 µU/mL (normal: 0.5-5.0 µU/mL)
Free thyroxine (T4): 0.5 ng/dL (normal: 0.9-1.7 ng/dL)

Which of the following is the most appropriate action in the management of this patient?

Show answer & explanation

Answer: Recommend structured psychotherapy aimed at cognitive restructuring

Answer

Recommend structured psychotherapy aimed at cognitive restructuring
The correct answer recommends structured psychotherapy aimed at cognitive restructuring (Cognitive-Behavioral Therapy, CBT). This patient meets the DSM-5 criteria for Generalized Anxiety Disorder (GAD), characterized by excessive worry across multiple domains for at least 6 months, accompanied by somatic symptoms such as muscle tension and fatigue. Both CBT and selective serotonin reuptake inhibitors (SSRIs) are first-line treatments for GAD. However, this patient was recently started on phenelzine, a monoamine oxidase inhibitor (MAOI). The concomitant use of an MAOI and a serotonergic agent (like an SSRI) is absolutely contraindicated due to the high risk of precipitating potentially fatal serotonin syndrome. Therefore, initiating a non-pharmacologic first-line therapy like CBT is the safest and most appropriate next step.

Step-by-Step Solution

1
Analyze the patient's primary psychiatric symptoms.
The patient presents with 7 months of excessive, multi-domain worry, fatigue, and muscle tension.
These symptoms fulfill the DSM-5 diagnostic criteria for Generalized Anxiety Disorder (GAD).
2
Identify contraindications in the current medication regimen.
The patient is taking phenelzine, a monoamine oxidase inhibitor (MAOI).
MAOIs can cause life-threatening serotonin syndrome if combined with serotonergic medications like SSRIs or SNRIs, ruling out first-line pharmacotherapy for GAD.
3
Evaluate laboratory results to rule out medical mimics.
TSH is normal and Free T4 is low.
This pattern indicates central (secondary) hypothyroidism, not primary hypothyroidism (which presents with elevated TSH). Additionally, hypothyroidism causes fatigue rather than the excessive worry typical of GAD.
4
Determine the safest and most effective management step while maintaining ethical boundaries.
Recommend structured psychotherapy (CBT).
CBT is a first-line treatment for GAD, avoids the fatal risk of serotonin syndrome, and properly addresses her primary complaint without violating patient confidentiality.

Key Concept

First-line management of Generalized Anxiety Disorder (GAD) involves CBT or SSRI/SNRIs; however, CBT is the safest and most appropriate choice when pharmacotherapy is absolutely contraindicated (e.g., concurrent MAOI use).
Estimated Time:1m 30s
Question 489Question →

An emergency medical team brings a 35-year-old woman to the hospital due to the acute onset of confusion, severe agitation, and muscle twitching. The patient's husband reports that she has a long-standing history of treatment-resistant depression that has been managed with phenelzine for the past year. Four days ago, she consulted a different clinician for persistent low mood and was started on an additional psychiatric medication. Her vital signs show a temperature of 39.4°C (102.9°F), pulse of 124/min, respirations of 20/min, and blood pressure of 165/95 mm Hg. Physical examination reveals profuse diaphoresis, dilated pupils, a bilateral resting tremor, and pronounced hyperreflexia with spontaneous clonus in the lower extremities. The addition of which of the following medications most likely precipitated this patient's current condition?

Show answer & explanation

Answer: Citalopram

Answer

Citalopram
The correct answer is citalopram. This patient is experiencing serotonin syndrome, a potentially life-threatening condition characterized by the classic triad of altered mental status (confusion, agitation), autonomic instability (hyperthermia, tachycardia, diaphoresis), and neuromuscular hyperactivity (hyperreflexia, spontaneous clonus, tremor). This syndrome is most often precipitated by the concurrent use of two or more highly serotonergic medications. Phenelzine is an irreversible monoamine oxidase inhibitor (MAOI) that prevents the enzymatic breakdown of serotonin. Adding a selective serotonin reuptake inhibitor (SSRI) such as citalopram leads to a massive and rapid accumulation of synaptic serotonin, triggering this dangerous interaction. In clinical practice, MAOIs must be discontinued for at least 14 days before initiating an SSRI (and wait 5 weeks if switching from fluoxetine to an MAOI).

Step-by-Step Solution

1
Identify the clinical syndrome based on the physical examination and vital signs.
The patient exhibits fever, tachycardia, hypertension, altered mental status, diaphoresis, and severe neuromuscular hyperactivity (hyperreflexia and spontaneous clonus), which is the classic triad of Serotonin Syndrome.
Recognizing the distinct neuromuscular signs (clonus/hyperreflexia) helps differentiate Serotonin Syndrome from Neuroleptic Malignant Syndrome (which presents with rigidity).
2
Review the patient's baseline medication list to identify predisposing factors.
The patient takes phenelzine, which is a monoamine oxidase inhibitor (MAOI) that strongly inhibits the breakdown of serotonin in the central nervous system.
MAOIs carry a severe risk of drug-drug interactions, particularly with other serotonergic agents.
3
Determine which newly added psychiatric medication could trigger this syndrome when combined with an MAOI.
Citalopram, a selective serotonin reuptake inhibitor (SSRI), blocks serotonin reuptake. Combining it with an MAOI leads to massive serotonin accumulation.
A minimum 14-day washout period is required when switching between SSRIs and MAOIs to prevent this exact complication.

Key Concept

Serotonin syndrome resulting from the combination of a monoamine oxidase inhibitor (MAOI) and a selective serotonin reuptake inhibitor (SSRI).
Question 490Question →

During a routine home-visit evaluation, a geriatric psychiatrist examines a 73-year-old man whose daughter reports a 9-month history of progressive cognitive decline and unusual behaviors. The daughter emphasizes that his mental clarity fluctuates dramatically; he can be highly alert in the morning but profoundly lethargic and disorganized by the afternoon. Over the past 3 months, he has started seeing "strangers sitting on the living room couch," which causes him significant distress and agitation. For the past 4 years, he has exhibited violent thrashing and shouting movements during sleep. His medical history is significant for major depressive disorder, for which he has taken fluoxetine continuously for the last 5 years. Vital signs are within normal limits. Neurologic examination demonstrates bilateral cogwheel rigidity and a mild resting tremor in the left upper extremity. His Montreal Cognitive Assessment score is 20/30, featuring prominent deficits in visuospatial construction. The physician discusses management options with the daughter to address the patient's distressing visual hallucinations. Which of the following is the most appropriate next step in the pharmacologic management of this patient's condition?

Show answer & explanation

Answer: Initiate a central acetylcholinesterase inhibitor

Answer

The correct answer is to initiate a central acetylcholinesterase inhibitor.
The correct answer involves initiating a central acetylcholinesterase inhibitor (such as rivastigmine or donepezil). This patient's presentation of progressive cognitive decline, prominent fluctuations in alertness, recurrent well-formed visual hallucinations, parkinsonism (rigidity, resting tremor), and REM sleep behavior disorder is the classic clinical triad/tetrad for Major Neurocognitive Disorder with Lewy Bodies (DLB). In patients with DLB, acetylcholinesterase inhibitors are considered the first-line pharmacotherapy. They effectively reduce the frequency and severity of visual hallucinations and improve cognitive fluctuations. Importantly, they achieve this without carrying the severe morbidity and mortality risks associated with antipsychotic medications in this specific patient population.

Step-by-Step Solution

1
Identify the primary underlying syndrome based on the clinical presentation.
The combination of fluctuating cognition, well-formed visual hallucinations, parkinsonism (rigidity, resting tremor), and REM sleep behavior disorder establishes a diagnosis of Major Neurocognitive Disorder with Lewy Bodies (DLB).
Accurate diagnosis is required because DLB has unique pharmacological sensitivities compared to other neurocognitive disorders.
2
Determine the primary goal of the requested intervention.
The patient requires management for distressing visual hallucinations and agitation.
Treatment should target the specific symptom causing the most distress while avoiding harm to the patient.
3
Select the safest and most effective initial pharmacotherapy for DLB.
Central acetylcholinesterase inhibitors (e.g., rivastigmine, donepezil) are the treatment of choice.
These medications safely improve both cognitive and neuropsychiatric symptoms (including hallucinations) in DLB without the severe risks associated with antipsychotics.
4
Evaluate the remaining options for dangerous drug interactions or contraindications.
Haloperidol is ruled out due to the risk of severe neuroleptic sensitivity in DLB; selegiline is ruled out due to the risk of Serotonin Syndrome when combined with the patient's current fluoxetine prescription.
Ruling out dangerous psychopharmacological interactions confirms the safety and necessity of the correct choice.

Key Concept

Major Neurocognitive Disorder with Lewy Bodies presents with fluctuating cognition, visual hallucinations, parkinsonism, and REM sleep behavior disorder; initial pharmacotherapy for cognitive and behavioral symptoms should utilize acetylcholinesterase inhibitors while strictly avoiding typical antipsychotics.
Question 491Question →

Match each clinical vignette with the most appropriate psychiatric diagnosis from the somatic symptom and related disorders spectrum.

Click a left item, then click its matching right item

Items

A 28-year-old female medical resident is admitted for profound hypoglycemia (glucose 32 mg/dL). Labs show elevated insulin and low C-peptide. She denies medication use, tearfully demands a pancreatectomy for 'suspected insulinoma,' and has no external incentives.
A 45-year-old man involved in litigation following a minor car accident claims severe neck pain and cognitive disability. On formal neuropsychological testing, his performance is markedly worse than patients with severe brain injuries, showing inconsistent effort.
A 42-year-old man with occasional, mild caffeine-induced muscle twitches visits the clinic weekly, terrified he has Huntington disease. He spends hours daily researching the disease and checking his gait, despite consistently normal neurological exams.
A 38-year-old woman with a 3-year history of non-cardiac chest pain and fatigue has had multiple negative cardiac catheterizations. She states the pain is constantly on her mind and quit her job to rest, fearing an imminent heart attack.
A 25-year-old man develops sudden-onset right arm weakness after a marital argument. Examination reveals weakness during active elbow flexion but simultaneous palpable contraction of the triceps. He exhibits 'la belle indifférence' toward his deficit.

Matches

Show answer & explanation

Answer

Vignette 1 maps to Factitious disorder; Vignette 2 to Malingering; Vignette 3 to Illness anxiety disorder; Vignette 4 to Somatic symptom disorder; Vignette 5 to Functional neurological symptom disorder.
Each vignette provides pathognomonic clues to differentiate the psychiatric diagnoses. Intentional production with no external gain is factitious disorder; intentional production for external gain is malingering. Unconscious production with minimal symptoms but high disease fear is illness anxiety disorder; unconscious production with prominent physical symptoms is somatic symptom disorder; and incompatible neurologic findings indicate conversion disorder.

Step-by-Step Solution

1
Determine if the symptoms are intentionally produced or unconsciously experienced.
Vignettes 1 and 2 feature conscious deception; Vignettes 3, 4, and 5 involve unconscious symptom generation.
Establishing intent is the first critical branch point in evaluating somatic and factitious presentations.
2
Evaluate the motivation for the intentionally produced symptoms.
Vignette 1 involves primary gain (assuming the sick role) indicating Factitious disorder. Vignette 2 involves secondary gain (financial compensation) indicating Malingering.
The distinction between factitious disorder and malingering relies entirely on the presence or absence of an external incentive.
3
Analyze the focus of anxiety and symptom burden for the unconsciously produced symptoms.
Vignette 3 focuses on disease fear with minimal symptoms (Illness anxiety disorder). Vignette 4 focuses on prominent physical symptoms (Somatic symptom disorder). Vignette 5 presents with an anatomically incompatible neurological deficit (Functional neurological symptom disorder).
DSM-5 criteria differentiate these disorders based on symptom severity, chronicity, and specific neurologic incompatibility.

Key Concept

Differentiation of somatic symptom and related disorders based on intent, motivation, and symptom focus.
Question 492Question →

An accompanying friend brings a 2323-year-old female ballet dancer to the emergency department after the patient experienced an episode of syncope during a rehearsal. The friend notes that the patient has been increasingly obsessed with her weight, often skipping meals and expressing intense fear of becoming overweight despite appearing remarkably thin. Her current body mass index is 17.1 kg/m217.1 \text{ kg/m}^2.

On physical examination, blood pressure is 86/52 mmHg86/52 \text{ mmHg} and heart rate is 114/min114/\text{min}. Tapping over the facial nerve elicits a twitch of the nose and lips.

Initial laboratory studies reveal:

Laboratory TestResultReference Range
Sodium133 mEq/L133 \text{ mEq/L}136−145 mEq/L136-145 \text{ mEq/L}
Potassium2.2 mEq/L2.2 \text{ mEq/L}3.5−5.0 mEq/L3.5-5.0 \text{ mEq/L}
Chloride80 mEq/L80 \text{ mEq/L}95−105 mEq/L95-105 \text{ mEq/L}
Bicarbonate39 mEq/L39 \text{ mEq/L}22−28 mEq/L22-28 \text{ mEq/L}
Blood urea nitrogen42 mg/dL42 \text{ mg/dL}7−18 mg/dL7-18 \text{ mg/dL}
Creatinine1.5 mg/dL1.5 \text{ mg/dL}0.6−1.2 mg/dL0.6-1.2 \text{ mg/dL}
Ionized calcium3.6 mg/dL3.6 \text{ mg/dL}4.5−5.6 mg/dL4.5-5.6 \text{ mg/dL}
Magnesium1.0 mg/dL1.0 \text{ mg/dL}1.7−2.2 mg/dL1.7-2.2 \text{ mg/dL}

Arterial blood gas (room air):

ParameterResult
pH7.557.55
pCO2_249 mmHg49 \text{ mmHg}
pO2_294 mmHg94 \text{ mmHg}

Random urine studies:

TestResult
Urine chloride55 mEq/L55 \text{ mEq/L}

Which of the following is the most likely etiology of this patient's laboratory abnormalities?

Show answer & explanation

Answer: Pharmacological inhibition of the thick ascending limb sodium-potassium-chloride cotransporter

Answer

The correct etiology is the pharmacological inhibition of the thick ascending limb sodium-potassium-chloride cotransporter (covert loop diuretic abuse).
The correct answer describes the mechanism of action of loop diuretics, which inhibit the Na +^+-K +^+-22 Cl −^- cotransporter in the thick ascending limb of the loop of Henle. This patient, an elite dancer with body image distortion and a remarkably low BMI, suffers from an eating disorder. Her presentation of hypokalemia, hypochloremia, and profound metabolic alkalosis points to a purging mechanism. The critical distinguishing factor is her elevated random urine chloride (55 mEq/L55 \text{ mEq/L}). While vomiting (another common purging method) causes metabolic alkalosis, it is associated with a low urine chloride (<20 mEq/L<20 \text{ mEq/L}) because the functioning kidneys avidly reabsorb sodium and chloride to restore intravascular volume. In contrast, active diuretic use blocks chloride reabsorption, leading to high urine chloride despite systemic hypovolemia (evidenced by her elevated BUN/creatinine ratio). Furthermore, loop diuretics increase calcium excretion, explaining her hypocalcemia and resulting tetany (Chvostek sign), whereas thiazides would typically cause hypercalcemia.

Step-by-Step Solution

1
Analyze the arterial blood gas and serum electrolyte values.
The patient has a primary metabolic alkalosis (pH 7.557.55, HCO 3−_3^- 39 mEq/L39 \text{ mEq/L}) with appropriate respiratory compensation (pCO 2_2 49 mmHg49 \text{ mmHg}).
Establishing the primary acid-base disorder is the crucial first step in narrowing the differential diagnosis.
2
Evaluate the urine chloride concentration.
The urine chloride is elevated (55 mEq/L55 \text{ mEq/L}), indicating a saline-unresponsive etiology.
Urine chloride helps distinguish between volume-depleted states where the kidney reabsorbs chloride (e.g., vomiting, <20 mEq/L<20 \text{ mEq/L}) and states where chloride reabsorption is blocked (e.g., diuretic use, >20 mEq/L>20 \text{ mEq/L}).
3
Correlate physical findings and remaining electrolytes with the suspected etiology.
The hypocalcemia (3.6 mg/dL3.6 \text{ mg/dL}) causing Chvostek sign, along with hypomagnesemia, confirms the use of loop diuretics rather than thiazides.
Loop diuretics increase urinary calcium excretion, leading to hypocalcemia, whereas thiazide diuretics decrease urinary calcium excretion.

Key Concept

In patients with eating disorders, identifying the specific purging behavior relies on acid-base and electrolyte patterns. Loop diuretic abuse uniquely presents with hypokalemic, hypochloremic metabolic alkalosis, elevated urine chloride (>20 mEq/L>20 \text{ mEq/L}), and hypocalcemia.
Question 493Question →

Emergency medical responders transport a 48-year-old male to the trauma bay after he was found obtunded in his apartment. According to his live-in girlfriend, the patient has a history of treatment-resistant depression managed with phenelzine. She notes that over the past two days, he consumed multiple bottles of over-the-counter dextromethorphan for an upper respiratory infection. Vital signs upon arrival include a temperature of 39.9∘C39.9^\circ\text{C} (103.8∘F103.8^\circ\text{F}), heart rate of 132/min132/\text{min}, blood pressure of 170/105 mm Hg170/105\text{ mm Hg}, and respiratory rate of 24/min24/\text{min}. Physical examination is remarkable for profuse diaphoresis, hyperactive bowel sounds, and pronounced hyperreflexia with bilateral ankle clonus. The patient is stuporous and unable to communicate. A review of the electronic medical record reveals a legally executed advance directive designating the patient's sister as his sole healthcare proxy. Reached by telephone, the sister unequivocally requests that all life-sustaining and necessary medical treatments be provided. However, the girlfriend, who is present at the bedside, demands that no interventions be initiated, claiming the patient recently expressed a desire to 'die naturally without medical interference.' Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate cyproheptadine and supportive care in accordance with the sister's directive.

Answer

Initiate cyproheptadine and supportive care in accordance with the sister's directive.
The correct answer accurately combines the medical management of serotonin syndrome with appropriate ethical decision-making. The patient's presentation of autonomic instability, altered mental status, and marked neuromuscular hyperactivity (hyperreflexia, clonus) in the setting of phenelzine and dextromethorphan ingestion is classic for serotonin syndrome. The primary treatment includes supportive care and the serotonin antagonist cyproheptadine. Ethically, because the patient lacks capacity, the physician must rely on the legally appointed healthcare proxy—in this case, the sister—whose decisions override the informal requests of the live-in girlfriend.

Step-by-Step Solution

1
Diagnose the underlying acute medical emergency based on history and physical exam.
The combination of an MAOI (phenelzine), dextromethorphan, hyperthermia, autonomic instability, hyperactive bowel sounds, and hyperreflexia with clonus firmly points to Serotonin Syndrome.
Accurate identification of the toxidrome dictates the need for specific antidotal therapy (cyproheptadine) over contraindicated medications.
2
Assess the patient's decision-making capacity.
The patient is stuporous and unable to communicate, meaning he lacks the capacity to make his own medical decisions.
When a patient lacks capacity, a surrogate decision-maker must be identified to guide care.
3
Determine the legal surrogate decision-maker.
The electronic medical record explicitly names the sister as the designated healthcare proxy via a legally executed advance directive.
A legally designated proxy supersedes informal caregivers, partners, or next-of-kin who are not named in the directive.
4
Execute the management plan.
Proceed with the administration of cyproheptadine and aggressive supportive care (e.g., cooling, intravenous fluids, benzodiazepines) as authorized by the sister.
This aligns with both the correct medical protocol for serotonin syndrome and the legal/ethical framework of surrogate decision-making.

Key Concept

Management of Serotonin Syndrome and proper identification of the legal healthcare proxy in incapacitated patients.
Question 494Question →

A 24-year-old woman comes to the primary care clinic reporting feeling "constantly on edge" for the past 3 months. She states she has been worrying excessively about her academic performance, her finances, and her parents' health. The patient reports experiencing restlessness, muscle tension in her neck and shoulders, and difficulty concentrating on her studies. These symptoms began 3 months ago when she moved to a new city to start a rigorous graduate program. She acknowledges that the transition has been very stressful, and her academic performance has declined because she is so distracted by her worries. She denies any history of trauma, panic attacks, or periods of elevated mood. Her physical examination and laboratory studies, including thyroid-stimulating hormone, are within normal limits. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Adjustment disorder with anxiety

Answer

Adjustment disorder with anxiety
The correct answer is adjustment disorder with anxiety. This patient presents with excessive worry, restlessness, muscle tension, and impaired concentration that began shortly after a major life stressor (moving to a new city for graduate school). Crucially, these symptoms have caused significant functional impairment (academic decline). Adjustment disorder is diagnosed when emotional or behavioral symptoms develop within 3 months of an identifiable stressor and cause marked distress or functional impairment, provided the symptoms do not meet the criteria for another specific psychiatric disorder. Because her symptoms have only been present for 3 months, she does not yet meet the 6-month duration requirement for generalized anxiety disorder.

Step-by-Step Solution

1
Identify the primary symptoms and their duration.
The patient has excessive worry, restlessness, muscle tension, and poor concentration lasting for exactly 3 months.
Establishing the timeline and symptom profile is necessary to differentiate between various anxiety disorders.
2
Identify any triggering events and functional impact.
The symptoms began concurrently with moving for graduate school (an identifiable psychosocial stressor) and have caused an academic decline (functional impairment).
The presence of a stressor and functional impairment are key criteria for distinguishing pathology from a normal stress response.
3
Apply DSM-5 diagnostic criteria to rule out other disorders.
Generalized anxiety disorder requires 6 months of symptoms. Acute stress disorder requires a life-threatening trauma. Therefore, the presentation best fits an adjustment disorder.
Adjustment disorder is often a diagnosis of exclusion when symptoms triggered by a stressor do not meet the full duration or symptom criteria for another specific mental disorder.

Key Concept

Adjustment disorder is diagnosed when significant emotional or behavioral symptoms, leading to distress or functional impairment, develop within 3 months of a psychosocial stressor and do not meet criteria for another psychiatric disorder.
Estimated Time:1m 15s
Question 495Question →

A 32-year-old woman presents to the outpatient clinic with a 2-month history of severely depressed mood. She reports sleeping up to 14 hours a day, an increased appetite with a 5-kg (11-lb) weight gain, and a frequent sensation that her arms and legs are "made of lead." She states that she briefly feels better when her friends visit, but her low mood quickly returns. She has no prior psychiatric history and has never been treated for depression. She tearfully requests an antidepressant medication so she can return to her job as an accountant. Her vital signs and physical examination are unremarkable. Laboratory studies reveal a thyroid-stimulating hormone (TSH) level of 1.5 mU/L (normal: 0.4-4.0 mU/L) and a free T4 at the lower limit of normal. A urine toxicology screen is negative. The physician diagnoses a major depressive episode with atypical features and considers initiating pharmacotherapy. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Elicit a history of periods of elevated mood, impulsivity, and decreased need for sleep

Answer

The correct answer is to elicit a history of periods of elevated mood, impulsivity, and decreased need for sleep.
The correct next step is to screen the patient for a lifetime history of manic or hypomanic episodes. While this patient is currently experiencing a major depressive episode, atypical features (such as hypersomnia, weight gain, leaden paralysis, and mood reactivity) are particularly common in the depressive phase of bipolar disorder. Universal screening for bipolar disorder is required before initiating any antidepressant monotherapy. Failing to do so can lead to the inappropriate administration of an antidepressant (e.g., an SSRI), which carries a significant risk of inducing a manic switch or rapid cycling in patients with underlying bipolar disorder.

Step-by-Step Solution

1
Identify the current clinical syndrome.
The patient meets the criteria for a major depressive episode with atypical features (hypersomnia, hyperphagia, leaden paralysis, mood reactivity).
Recognizing the symptom cluster is required to establish the baseline diagnosis.
2
Determine the necessary safety and diagnostic checks prior to initiating antidepressant treatment.
The physician must screen for a history of mania or hypomania.
Antidepressant monotherapy can precipitate a manic episode (manic switch) in patients with undiagnosed bipolar disorder. Atypical depressive features specifically have a high correlation with bipolar depression.
3
Evaluate the provided options against standard psychiatric management guidelines.
Screening for manic/hypomanic symptoms is the only safe and appropriate next step before writing a prescription.
All other options involve inappropriate prescribing practices, contraindicated combinations, or incorrect application of diagnostic timelines.

Key Concept

Screening for bipolar disorder before initiating antidepressant monotherapy
Question 496Question →

A 38-year-old man, a self-employed clock repairman, presents to a primary care clinic for a physical examination required to renew his commercial driver's license. He has not interacted with the healthcare system in over a decade. During the interview, the patient is guarded and reluctant to answer questions regarding his medical history. When asked about his living situation, he becomes irritable, demanding to know why the physician is "prying into my personal life" and questioning whether the clinic intends to share his information with government agencies to revoke his license. The patient's brother, who is in the waiting room, privately informs the nurse that the patient has always been "highly suspicious" of others since his early twenties. The brother notes that the patient frequently accuses his clients of trying to defraud him and has completely cut off contact with several family members because he suspects they are secretly plotting to ruin his business. The patient has never experienced hallucinations, his speech is goal-directed and organized, and he does not hold magical or bizarre beliefs. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Paranoid personality disorder

Answer

Paranoid personality disorder
The correct answer is paranoid personality disorder. This condition is characterized by a pervasive and long-standing pattern of distrust and suspiciousness of others. Patients frequently interpret the motives of others as malevolent, bear grudges, and suspect that others are exploiting or deceiving them without sufficient basis. This patient's lifelong history (since his early twenties) of suspecting government agencies, clients, and family members of plotting against him perfectly aligns with this diagnosis. Crucially, he does not exhibit fixed, bizarre delusions or hallucinations, which distinguishes his condition from primary psychotic disorders.

Step-by-Step Solution

1
Analyze the patient's primary symptoms and their duration.
The patient exhibits pervasive distrust and suspiciousness across multiple contexts (clinic, clients, family) starting in early adulthood.
Establishing the core symptom cluster and its timeline differentiates personality disorders from acute psychotic episodes.
2
Evaluate for the presence of true psychotic features.
There are no hallucinations, disorganized speech, magical thinking, or fixed delusions localized to a single false belief.
The absence of these features rules out primary psychotic disorders like schizophrenia or delusional disorder.
3
Differentiate among Cluster A personality disorders.
The primary presentation is active suspicion and distrust, rather than emotional detachment (schizoid) or odd, magical beliefs (schizotypal).
Cluster A disorders share a genetic relationship with schizophrenia but have distinct clinical presentations.

Key Concept

Paranoid personality disorder is characterized by a pervasive, lifelong pattern of distrust and suspiciousness of others, interpreting their motives as malevolent, without the presence of fixed delusions or other psychotic features.
Question 497Question →

A primary care physician is evaluating a 71-year-old retired mechanic who is accompanied by his son. The son reports that over the past 14 months, his father has exhibited progressive short-term memory loss, missed several bill payments, and recently struggled to recall the names of his grandchildren. The patient feels he is "doing just fine" and is mildly annoyed by the visit. Vital signs are normal, and the neurological examination is nonfocal. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for evaluating and managing this patient's suspected major neurocognitive disorder, from initial clinical assessment to definitive management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with objective cognitive screening, followed by screening for reversible metabolic causes, obtaining structural neuroimaging, considering specialized biomarker testing if indicated, and concluding with a comprehensive management and safety plan.
The standard of care for evaluating insidious cognitive decline follows a stepwise approach designed to minimize unnecessary testing while safely ruling out reversible etiologies. The clinician must first objectively confirm the cognitive deficit (Step 1). Subsequently, easily reversible systemic, endocrine, and metabolic causes are excluded via basic laboratory testing (Step 2). Once metabolic causes are ruled out, structural neuroimaging is obtained to identify vascular changes, space-occupying lesions, or distinct neurodegenerative atrophy patterns (Step 3). If the diagnosis remains equivocal, advanced functional imaging or cerebrospinal fluid biomarker testing may be considered (Step 4). Finally, once a diagnosis is established, a comprehensive management plan addressing safety, pharmacology, and long-term care is implemented (Step 5).

Step-by-Step Solution

1
Confirm cognitive impairment.
Use of the Montreal Cognitive Assessment or Mini-Mental State Examination.
Before pursuing a costly and potentially invasive diagnostic workup, the presence and severity of cognitive deficits must be objectively established.
2
Rule out reversible metabolic or systemic causes.
Ordering vitamin B12, TSH, comprehensive metabolic panel, and complete blood count.
Hypothyroidism, vitamin B12 deficiency, and various metabolic derangements can present as pseudodementia and are easily treatable if identified early.
3
Evaluate for structural intracranial pathology.
Performing a non-contrast brain MRI (or CT).
Structural imaging rules out space-occupying lesions, normal pressure hydrocephalus, and vascular dementia while evaluating for characteristic neurodegenerative atrophy patterns.
4
Differentiate complex or atypical etiologies.
Considering FDG-PET, amyloid PET, or lumbar puncture.
If the presentation is atypical (e.g., early-onset) or the distinction between Alzheimer disease and frontotemporal dementia is unclear, specialized biomarkers are utilized.
5
Establish long-term management and safety parameters.
Discussing driving cessation, advance directives, and prescribing medications like cholinesterase inhibitors.
Appropriate medical and social management is tailored based on the definitive diagnosis reached through the preceding diagnostic cascade.

Key Concept

Diagnostic Algorithm for Major Neurocognitive Disorders
Question 498Question →

A 24-year-old woman is evaluated in the outpatient psychiatry clinic. She reports a 4-week history of severe sadness, loss of interest in her usual activities, hypersomnia, and low energy. She is diagnosed with major depressive disorder and prescribed escitalopram. The physician counsels her extensively on what to expect during the course of her treatment. Arrange the following clinical events in the typical chronological order of their occurrence after initiating this pharmacotherapy, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The typical chronological sequence is: onset of gastrointestinal side effects (hours to days), improvement in neurovegetative symptoms like energy and sleep (1-2 weeks), improvement in subjective mood (4-6 weeks), and finally, achievement of maximal therapeutic benefit (8-12 weeks).
The timeline of selective serotonin reuptake inhibitor (SSRI) response follows a distinct and predictable sequence. Adverse effects, such as gastrointestinal upset (nausea, diarrhea) or headache, occur almost immediately (within hours to days) due to acute serotonin reuptake inhibition. The earliest therapeutic benefit is observed in neurovegetative symptoms (sleep, energy, appetite), which typically begin to improve at 1 to 2 weeks. Core affective symptoms, including depressed mood and anhedonia, take longer and typically begin to improve at 4 to 6 weeks. Finally, maximal therapeutic benefit and potential remission may require 8 to 12 weeks of continuous treatment.

Step-by-Step Solution

1
Identify the event with the earliest onset after initiating an SSRI.
Gastrointestinal adverse effects.
These occur almost immediately (within hours to days) due to acute stimulation of serotonin receptors.
2
Identify the earliest therapeutic response.
Improvement in neurovegetative symptoms.
Sleep, appetite, and energy levels typically improve first, around weeks 1 to 2 of treatment.
3
Determine when the core mood symptoms begin to respond.
Reduction in subjective sadness.
Affective symptoms require 4 to 6 weeks to show noticeable improvement.
4
Identify the final event in the treatment timeline.
Maximum therapeutic benefit.
Full remission or maximal response often takes 8 to 12 weeks of continuous therapy.

Key Concept

Timeline of SSRI therapeutic response and side effects
Question 499Question →

A 26-year-old26\text{-year-old} female graduate student presents to the outpatient psychiatry clinic accompanied by her roommate due to worsening isolation and depression. For the past 3 weeks3 \text{ weeks}, the patient has stayed in her room, slept up to 14 hours14 \text{ hours} a day, and consumed large amounts of junk food, leading to a 4 kg4 \text{ kg} (8.8 lb8.8 \text{ lb}) weight gain. She tells the physician, "I am a failure and I hear a voice whispering that I should just give up." Her roommate mentions that the patient has been taking an over-the-counter herbal supplement, St. John's wort, for the past 2 months2 \text{ months} to "help with her mood," but it has not provided any relief.

Review of her psychiatric history reveals that 2 years2 \text{ years} ago, she had a distinct 6-day6\text{-day} period where she felt "incredibly energized," slept only 3 hours3 \text{ hours} per night, and simultaneously wrote three term papers while serving as the president of a student club. She did not require hospitalization during that time, and her overall functioning was arguably enhanced.

Her vital signs and physical examination are normal. Laboratory studies, including a TSH of 4.5 \muU/mL4.5 \text{ \mu U/mL} (normal: 0.5−5.0 \muU/mL0.5 - 5.0 \text{ \mu U/mL}) and a free T4 of 0.9 ng/dL0.9 \text{ ng/dL} (normal: 0.8−1.8 ng/dL0.8 - 1.8 \text{ ng/dL}), are unremarkable.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue St. John's wort and initiate quetiapine

Answer

Discontinue St. John's wort and initiate quetiapine
The correct action is to discontinue St. John's wort and initiate quetiapine. This patient presents with a major depressive episode (hypersomnia, weight gain, depressed mood) accompanied by mood-congruent psychotic features (hearing a whispering voice). However, her history of a 6-day episode of elevated energy, decreased need for sleep, and hyper-productivity that did not cause severe impairment represents a past hypomanic episode. Therefore, her correct diagnosis is Bipolar II disorder. The first-line treatment for bipolar depression includes atypical antipsychotics such as quetiapine or lurasidone, which effectively target both the depressive and psychotic symptoms. St. John's wort should be discontinued because it is ineffective for severe bipolar depression and acts as a potent CYP3A4 inducer, which would decrease the serum concentration of quetiapine.

Step-by-Step Solution

1
Synthesize the patient's current presentation.
The patient is experiencing a major depressive episode (depressed mood, hypersomnia, weight gain) with mood-congruent psychotic features (auditory hallucinations) lasting 3 weeks.
Establishing the current syndrome is necessary to guide acute management.
2
Evaluate the patient's psychiatric history for previous mood episodes.
The patient has a history of a distinct 6-day period of elevated energy, decreased need for sleep, and hyper-productivity without severe impairment.
A past hypomanic episode changes the diagnosis from Major Depressive Disorder to Bipolar II Disorder, fundamentally altering the treatment algorithm.
3
Review laboratory results to rule out secondary causes.
TSH and Free T4 are within normal limits.
Medical etiologies such as hypothyroidism must be excluded before finalizing a primary psychiatric diagnosis.
4
Select the appropriate pharmacotherapy and manage current medications.
Initiate quetiapine to treat the bipolar depression and psychosis, and discontinue St. John's wort.
Antidepressant monotherapy is contraindicated in bipolar disorder. Quetiapine treats both the mood and psychotic symptoms. St. John's wort is a CYP3A4 inducer (which lowers quetiapine levels) and carries serotonergic risks.

Key Concept

Bipolar depression with psychotic features requires treatment with agents that target both mood and psychosis (e.g., quetiapine, lurasidone), while avoiding antidepressant monotherapy due to the risk of a manic switch.
Estimated Time:2m 0s
Question 500Question →

A 16-year-old girl is hospitalized for severe malnutrition secondary to anorexia nervosa, restricting subtype. Her body mass index (BMI) is 13.2 kg/m213.2 \text{ kg/m}^2. The medical team plans to initiate careful nutritional rehabilitation but is acutely concerned about a potentially fatal metabolic complication characterized by severe electrolyte derangements. Arrange the following pathophysiological steps of this syndrome in the correct chronological sequence, starting from the initial dietary trigger to the ultimate clinical manifestations.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence begins with the reintroduction of carbohydrates, followed by an abrupt insulin surge, leading to the intracellular shift of electrolytes. This causes profound hypophosphatemia and decreased ATP synthesis, ultimately culminating in life-threatening clinical complications.
Refeeding syndrome pathogenesis follows a strict sequence: Carbohydrate intake triggers massive insulin release. Insulin drives phosphate, potassium, and magnesium into cells. The resulting intravascular hypophosphatemia impairs cellular ATP production, leading to widespread cardiopulmonary and neurologic failure.

Step-by-Step Solution

1
Identify the clinical complication being described in the vignette.
The scenario describes refeeding syndrome in a severely malnourished patient with anorexia nervosa.
Patients with a very low BMI are at high risk for rapid, life-threatening metabolic derangements when feeding is restarted.
2
Determine the initial physiological trigger of the syndrome.
Reintroduction of carbohydrates is the very first step in the sequence.
Carbohydrates provide the glucose load that forcibly shifts the body out of its starvation-adapted catabolic state.
3
Identify the hormonal response to the carbohydrate load.
An abrupt surge in endogenous insulin secretion occurs.
Insulin is quickly released by the pancreas to manage the sudden influx of serum glucose and promote cellular anabolism.
4
Determine the immediate cellular effect of the insulin surge.
Rapid intracellular shifting of phosphate, potassium, and magnesium.
Insulin directly drives glucose and these crucial electrolytes from the serum into the intracellular space.
5
Identify the metabolic consequence of this rapid electrolyte shift.
Profound serum hypophosphatemia and decreased ATP synthesis.
Phosphate is depleted from the serum, severely limiting the generation of ATP, which is essential for cellular energy.
6
Determine the final clinical outcome of the profound energy depletion.
Onset of clinical complications like heart failure, arrhythmias, or seizures.
Target organs fail due to the severe lack of ATP and the arrhythmogenic effects of the combined electrolyte deficits.

Key Concept

Refeeding syndrome is a fatal complication of nutritional rehabilitation in severe malnutrition, fundamentally driven by an insulin surge that causes intracellular shifts of phosphate, potassium, and magnesium, resulting in profound ATP depletion and subsequent multiorgan failure.
Estimated Time:1m 30s
PreviousPage 25 / 41Next
Psychiatry Practice Questions — USMLE Step 2 CK — Page 25 | Examkin